These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2222347)

  • 1. Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty.
    Nye ER; Ablett MB; Robertson MC; Ilsley CD; Sutherland WH
    Aust N Z J Med; 1990 Aug; 20(4):549-52. PubMed ID: 2222347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Schwartz L; Bourassa MG; Lespérance J; Aldridge HE; Kazim F; Salvatori VA; Henderson M; Bonan R; David PR
    N Engl J Med; 1988 Jun; 318(26):1714-9. PubMed ID: 2967433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty.
    Bourassa MG; Lespérance J; Eastwood C; Schwartz L; Côté G; Kazim F; Hudon G
    J Am Coll Cardiol; 1991 Aug; 18(2):368-76. PubMed ID: 1856404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids.
    Dehmer GJ; Popma JJ; van den Berg EK; Eichhorn EJ; Prewitt JB; Campbell WB; Jennings L; Willerson JT; Schmitz JM
    N Engl J Med; 1988 Sep; 319(12):733-40. PubMed ID: 2842680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
    Tanabe Y; Ito E; Nakagawa I; Suzuki K
    Int J Cardiol; 2001 May; 78(3):285-91. PubMed ID: 11376832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.
    Hoberg E; Dietz R; Frees U; Katus HA; Rauch B; Schömig A; Schuler G; Schwarz F; Tillmanns H; Niebauer J
    Br Heart J; 1994 Mar; 71(3):254-60. PubMed ID: 8142195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty.
    Lembo NJ; Black AJ; Roubin GS; Wilentz JR; Mufson LH; Douglas JS; King SB
    Am J Cardiol; 1990 Feb; 65(7):422-6. PubMed ID: 2407084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of acute complications after percutaneous transluminal coronary angioplasty.
    Bourassa MG; Schwartz L; Lespérance J; Eastwood C; Kazim F
    Thromb Res Suppl; 1990; 12():51-8. PubMed ID: 2082488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous transluminal coronary angioplasty in patients with spasm superimposed on atherosclerotic narrowing.
    Bertrand ME; Lablanche JM; Fourrier JL; Traisnel G
    Br Heart J; 1987 Nov; 58(5):469-72. PubMed ID: 2960366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty.
    Grigg LE; Kay TW; Valentine PA; Larkins R; Flower DJ; Manolas EG; O'Dea K; Sinclair AJ; Hopper JL; Hunt D
    J Am Coll Cardiol; 1989 Mar; 13(3):665-72. PubMed ID: 2537349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty.
    Knudtson ML; Flintoft VF; Roth DL; Hansen JL; Duff HJ
    J Am Coll Cardiol; 1990 Mar; 15(3):691-7. PubMed ID: 2105988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty.
    Schwartz L; Lesperance J; Bourassa MG; Eastwood C; Kazim F; Arafah M; Ganassin L
    Am Heart J; 1990 Feb; 119(2 Pt 1):232-6. PubMed ID: 2405609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance.
    Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
    J Am Coll Cardiol; 1996 Nov; 28(5):1119-26. PubMed ID: 8890804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fish oil supplements for prevention of restenosis after coronary angioplasty.
    Kaul U; Sanghvi S; Bahl VK; Dev V; Wasir HS
    Int J Cardiol; 1992 Apr; 35(1):87-93. PubMed ID: 1563884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive intracoronary dipyridamole in the interventional treatment of small coronary arteries: a prospectively randomized trial.
    Heidland UE; Heintzen MP; Michel CJ; Strauer BE
    Am Heart J; 2000 Jun; 139(6):1039-45. PubMed ID: 10827385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angioscopic prediction of successful dilatation and of restenosis in percutaneous transluminal coronary angioplasty. Significance of yellow plaque.
    Itoh A; Miyazaki S; Nonogi H; Daikoku S; Haze K
    Circulation; 1995 Mar; 91(5):1389-96. PubMed ID: 7867178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group.
    Faxon DP
    J Am Coll Cardiol; 1995 Feb; 25(2):362-9. PubMed ID: 7829789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can supplementation of diet with omega-3 polyunsaturated fatty acids reduce coronary angioplasty restenosis rate?
    Bellamy CM; Schofield PM; Faragher EB; Ramsdale DR
    Eur Heart J; 1992 Dec; 13(12):1626-31. PubMed ID: 1289091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.